Immix Biopharma Cash Flow Statement 2019-2024 | IMMX

Fifteen years of historical annual cash flow statements for Immix Biopharma (IMMX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-15.60$-8.23$-24.38$-1.15$-0.97
$0.01$0.00$0.06$0.00$0.00
$2.57$0.62$23.13$0.58$0
$2.57$0.63$23.19$0.58$0.00
$-0.89$-0.24$0.10$0.06$-0.04
$0$0$0$0$0
$0$0$0$0$0
$0.11$-0.69$-0.50$0.01$0.00
$1.65$0.20$-0.39$0.17$0.18
$-11.37$-7.41$-1.59$-0.40$-0.79
$-0.05$0$0.00$0$-0.01
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$-0.05$0$0.00$0$-0.01
$0$0$0$0$0
$0$-0.05$0.20$0$1.05
$0$-0.05$0.20$0$1.05
$15.70$3.29$18.65$0$0
$15.70$3.29$18.65$0$0
$0$0$0$0$0
$-0.23$-0.01$0$0$0
$15.46$3.23$18.85$0$1.05
$4.07$-4.21$17.25$-0.34$0.27
$2.57$0.62$0.28$0$0
$0$0$0$0$0